Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine Tumors

Journal article published in 2017 by Sebastian Krug, Michael Boch, Peter Rexin, Thomas M. Gress

, Patrick Michl, Anja Rinke

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by